title: Hormone therapy in men-increased risk of cardiac allograft rejection?
authors.forename: R
authors.initials: R
authors.lastname: Tandler
authors.forename: M
authors.initials: M
authors.lastname: Kondruweit
authors.forename: T
authors.initials: T
authors.lastname: Fischlein
authors.forename: M
authors.initials: M
authors.lastname: Weyand
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000453:epidemiology; D006084:Graft Rejection / Q000139:chemically induced* / Q000453:epidemiology*; D016027:Heart Transplantation; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000453:epidemiology; D012307:Risk Factors; D013318:Stroke Volume / Q000187:drug effects; D013739:Testosterone / Q000009:adverse effects; D016277:Ventricular Function, Left / Q000187:drug effects
chemical_list: D013739:Testosterone; D016729:Leuprolide